Related Experiment Videos
p53 point mutation in HPV negative human cervical carcinoma cell lines
T Crook1, D Wrede, K H Vousden
1Ludwig Institute for Cancer Research, St Mary's Hospital Medical School, London, UK.
Oncogene
|May 1, 1991
Summary
Transforming human papilloma viruses (HPVs) are linked to cervical cancer. This study found that loss of wild-type p53 function, through mutation or viral proteins, is crucial for cervical carcinoma development.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Transforming human papilloma viruses (HPVs) are implicated in anogenital carcinoma etiology.
- Cervical carcinoma can occur independently of HPV presence.
- The role of p53 gene in cervical cancer development requires further elucidation.
Purpose of the Study:
- To analyze the p53 mRNA sequence in HPV-positive and HPV-negative cervical carcinoma cell lines.
- To investigate the correlation between p53 gene status and HPV infection in cervical cancer.
- To understand the mechanisms leading to p53 dysfunction in cervical carcinogenesis.
Main Methods:
- Direct cDNA/PCR sequencing protocol.
- Analysis of p53 mRNA sequences in six HPV-positive and two HPV-negative cervical carcinoma cell lines.
- Identification of mutations in evolutionarily conserved regions of the p53 gene.
Main Results:
- HPV-positive cell lines expressed wild-type p53 mRNA across conserved regions.
- Two HPV-negative cell lines (C33a and HT3) exhibited mutant p53 mRNA.
- Mutations in HPV-negative cell lines occurred in evolutionarily conserved amino acids.
Conclusions:
- Loss of wild-type p53 function is a significant factor in cervical carcinoma development.
- p53 dysfunction can result from p53 gene mutations or viral p53-binding proteins.
- These findings highlight distinct pathways in cervical carcinogenesis related to HPV status.